NovoCure Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for NovoCure Limited (NVCR) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.160.240.970.940.840.330.25
Short-Term Investments0.800.670.850.730.610.000.00
Cash & Short-Term Investments0.960.910.970.940.840.330.25
Accounts Receivable0.100.060.090.090.100.060.05
Inventory0.040.040.030.020.030.020.02
Other Current Assets0.010.010.010.030.030.000.00
Total Current Assets1.111.031.111.071.000.440.32
Non-Current Assets
Property, Plant & Equipment (Net)0.120.100.060.040.030.020.02
Other Non-Current Assets0.010.010.040.010.010.040.00
Total Non-Current Assets0.130.110.080.070.050.040.02
Total Assets1.241.151.191.141.050.480.34
Current Liabilities
Accounts Payable0.110.090.160.140.110.090.06
Short-Term Debt0.570.000.000.000.000.000.00
Current Portion of Long-Term Debt0.560.000.000.000.000.000.00
Accrued Liabilities0.070.060.060.050.040.000.00
Deferred Revenue0.010.020.020.020.020.000.00
Other Current Liabilities0.070.010.040.040.030.000.00
Total Current Liabilities0.760.180.160.140.110.090.06
Non-Current Liabilities
Long-Term Debt0.120.570.580.580.440.160.15
Other Non-Current Liabilities0.010.000.000.000.000.000.00
Total Non-Current Liabilities0.120.600.590.590.460.180.16
Total Liabilities0.880.780.750.730.580.260.23
Stockholders' Equity
Retained Earnings-1.15-0.99-0.78-0.69-0.63-0.65-0.64
Accumulated Other Comprehensive Income-0.01-0.010.000.000.000.000.00
Additional Paid-in Capital1.521.351.221.101.110.870.76
Shares Outstanding0.110.110.110.100.000.000.00
Total Stockholders' Equity0.360.360.440.410.480.220.11
Total Liabilities & Equity1.241.151.191.141.050.480.34